Literature DB >> 29029120

Diagnostic Usefulness of Varicella-Zoster Virus Real-Time Polymerase Chain Reaction Analysis of DNA in Saliva and Plasma Specimens From Patients With Herpes Zoster.

Seong Yeon Park1, Ji Yeun Kim2, Ji-Ae Kim2, Ji-Soo Kwon2, Sun-Mi Kim2, Na Young Jeon2, Min-Chul Kim2, Yong Pil Chong2, Sang-Oh Lee2, Sang-Ho Choi2, Yang Soo Kim2, Jun Hee Woo2, Sung-Han Kim2.   

Abstract

Background: We evaluated the diagnostic usefulness of polymerase chain reaction (PCR) analysis for detecting varicella-zoster virus (VZV) infection and reactivation of VZV, using DNA extracted from saliva and plasma specimens obtained from subjects with suspected herpes zoster and from healthy volunteers during stressful and nonstressful conditions.
Methods: There were 52 patients with a diagnosis of herpes zoster (group 1), 30 with a diagnosis of zoster-mimicking disease (group 2), and 27 healthy volunteers (group 3). Saliva and plasma samples were evaluated for VZV DNA by real-time PCR analysis.
Results: Among patients with suspected herpes zoster (ie, patients in groups 1 and 2), the sensitivity of PCR analysis of salivary DNA for detecting VZV (88%; 95% confidence interval [CI], 74%-95%) was significantly higher than that of PCR analysis of plasma DNA (28%; 95% CI, 16%-44%; P < .001), whereas the specificity of PCR analysis of salivary DNA (100%; 95% CI, 88%-100%) was similar to that of PCR analysis of plasma DNA (100%; 95% CI, 78%-100%; P > .99). VZV DNA was not detected in saliva and plasma samples from group 3 (0%; 95% CI, 0%-14%). Conclusions: Real-time PCR analysis of salivary DNA is more sensitive than that of plasma DNA for detecting VZV among patients with suspected herpes zoster. We found no subclinical reactivation of VZV in group 3 following exposure to common stressful conditions.
© The Author 2017. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Herpes zoster; plasma; saliva; varicella-zoster virus (VZV)

Mesh:

Substances:

Year:  2017        PMID: 29029120     DOI: 10.1093/infdis/jix508

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  5 in total

1.  Non-dermatomal cutaneous herpes zoster infection in a solid-organ transplant patient.

Authors:  Bao Vincent K Ho; Sarah Pourakbar; Christopher Tomassian; Anand Rajpara
Journal:  IDCases       Date:  2022-06-20

2.  Herpes Zoster in Kidney Transplant Recipients: Detection of VZV DNA in Blood During the Prodromal Phase.

Authors:  Anne Devin; Edith Renoult; Michel Roger; Marie-Josée Hébert
Journal:  Transplant Direct       Date:  2018-05-02

3.  Simple and label-free pathogen enrichment via homobifunctional imidoesters using a microfluidic (SLIM) system for ultrasensitive pathogen detection in various clinical specimens.

Authors:  Choong Eun Jin; Bonhan Koo; Eun Yeong Lee; Ji Yeun Kim; Sung-Han Kim; Yong Shin
Journal:  Biosens Bioelectron       Date:  2018-04-03       Impact factor: 10.618

4.  Management of herpesvirus reactivations in patients with solid tumours and hematologic malignancies: update of the Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO) on herpes simplex virus type 1, herpes simplex virus type 2, and varicella zoster virus.

Authors:  Larissa Henze; Christoph Buhl; Michael Sandherr; Oliver A Cornely; Werner J Heinz; Yascha Khodamoradi; Til Ramon Kiderlen; Philipp Koehler; Alrun Seidler; Rosanne Sprute; Martin Schmidt-Hieber; Marie von Lilienfeld-Toal
Journal:  Ann Hematol       Date:  2022-01-07       Impact factor: 3.673

Review 5.  Vaccination for herpes zoster in patients with solid tumors: a position paper on the behalf of the Associazione Italiana di Oncologia Medica (AIOM).

Authors:  P Pedrazzoli; A Lasagna; I Cassaniti; A Ferrari; F Bergami; N Silvestris; E Sapuppo; M Di Maio; S Cinieri; F Baldanti
Journal:  ESMO Open       Date:  2022-07-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.